Showing results (181-190 of 270) with videos related to
Sort By:
Pageof 27
BMJ Open|July 16, 2026
Personalised approach to hypertension treatment: protocol for the HYPERMARKER randomised controlled trialMatthew Chapman, Jonathan E Knikman, Alastair Mobley, et al.Journal of the American Heart Association|December 22, 2021
Impact of a Patient's Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision MakingTamar I de Vries, Manon C Stam-Slob, Ron J G Peters, et al.Frontiers in Surgery|February 2, 2023
Functional outcome of arterial thoracic outlet syndrome treatmentRobert J C M F de Kleijn, Ludo Schropp, Jan Westerink, et al.Cardiovascular Diabetology|November 10, 2021
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetesShahnam Sharif, Y Van der Graaf, M J Cramer, et al.Diabetes Care|May 23, 2018
Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 DiabetesNordin M J Hanssen, Jan Westerink, Jean L J M Scheijen, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 11, 2018
Editor's Choice - Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting: A Systematic Review and Meta-analysisAnne E Huibers, Jan Westerink, Evelien E de Vries, et al.Diabetes Care|August 27, 2015
Body weight, metabolic dysfunction, and risk of type 2 diabetes in patients at high risk for cardiovascular events or with manifest cardiovascular disease: a cohort studyBas T Franssens, Yolanda van der Graaf, L Jaap Kappelle, et al.Heart (British Cardiac Society)|January 5, 2024
Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Martin Teraa, et al.Hypertension (Dallas, Tex. : 1979)|November 5, 2021
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence TestingDan Lane, Alexander Lawson, Angela Burns, et al.Diabetes, Obesity & Metabolism|May 8, 2019
Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohortShahnam Sharif, Rolf H H Groenwold, Yolanda van der Graaf, et al.Pageof 27